New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
New research reveals KGM’s unique ability to boost GLP-1 secretion and modulate gut microbiome, offering metabolic advantages over other fibers and synthetic drugs. Groundbreaking mouse studies ...
Cutting-edge research explores how GI hormones like ghrelin, leptin, and GLP-1 reshape hunger and fullness. Discover their clinical potential and the promise of personalized obesity therapies. Gastroi...
